The largest database of trusted experimental protocols

Freund s complete or incomplete adjuvant

Manufactured by Merck Group
Sourced in United States

Freund's complete or incomplete adjuvant is a laboratory reagent used to enhance the immune response to an antigen. The complete adjuvant contains killed Mycobacterium tuberculosis, while the incomplete adjuvant does not contain the mycobacterial component. Both formulations are used in research applications to stimulate a stronger immune response when administered with an antigen.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using freund s complete or incomplete adjuvant

1

Production and Characterization of Anti-CsMF6p/HDM Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-CsMF6p/HDM was produced by immunizing BALB/c mice with the purified rCsMF6p/HDM. The protein (100 μg) was mixed with Freund’s complete or incomplete adjuvant (Sigma-Aldrich, St. Louis, MO, USA) and injected into mice intraperitoneally three times at 2-week intervals. Two weeks after the final booster, the mice were sacrificed and the sera were collected. The immunoglobulin G (IgG) fraction was further purified with the Protein G agarose (Pierce, Rockford, lL, USA) according to the manufacturer’s instructions. The specificity of the anti-CsMF6p/HDM was confirmed by immunoblot analysis.
+ Open protocol
+ Expand
2

Immunization Efficacy of H6HA1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female BALB/c mice (6 weeks old) were purchased from the National Laboratory Animal Center, Taiwan, and three mice were used per inoculation group. For every inoculation, 100 μg recombinant H6HA1-His protein was emulsified with equal volume of Freund's complete or incomplete adjuvant (Sigma, USA). During the 10-week immunization schedule (five booster shoots at every 2-week interval), mouse sera were collected and analyzed for specificity using Western blotting against antigens including the expressed H6HA1-His proteins from Escherichia coli or baculovirus, and two subtypes of AIV (the H6 subtype [A/chicken/Taiwan/2838 V/00] and the H5 subtype [A/Duck/Taiwan/3233/04]), which were provided by Professor Ching-Ho Wang (Department of Veterinary Medicine, National Taiwan University, Taiwan). These animal experiments were approved by the Institutional Animal Care and Use Committee of National Taiwan University.
+ Open protocol
+ Expand
3

SFTSV NP Protein Expression and Antibody Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NP gene of SFTSV was amplified by reverse transcription PCR (RT-PCR) with the Access RT-PCR System Kit (Promega, Madison, WI). The sequences of the forward primer and reverse primer were: GAG GTA CCA TGT CAG AGT GGT CC and AAT CTC GAG TTA CAG GTT CCT GTA AG, respectively. The amplification conditions and parameters were as follows: one cycles at 45 °C for 45 min, 94 °C for 2 min, 40 cycles at 94 °C for 30s, 60 °C for 1 min, 68 °C for 2 min, one cycles at 68 °C for 7 min. The PCR product was cloned into pMD19 (Simple) T-Vectors (Clontech Laboratories, CA). The cloned insert was excised from the recombinant vector by double enzyme digestion and sub-cloned into pet-32a vector to express the NP. The recombinant NP was purified with the pET Express & Purify Kit—His60 (Clontech Laboratories, CA).
The purified recombinant NP was mixed with equal volume complete or incomplete Freund’s adjuvant (Sigma-Aldrich, USA) and injected subcutaneously into six 6- to 8-weekold Kunming mice (The Animal Experiment Center of Shandong University, Jinan City, China) to make polyclonal antibody. Each mouse was injected with 100 μg recombinant protein at multiple sites at one-week interval for 4 times. Mice were sacrificed 15 days after the last immunization to obtain sera. Sera were frozen at − 80 °C until use as the primary antibody.
+ Open protocol
+ Expand
4

Preparation of Chicken Immunosera Against NDV

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare the chicken immunosera against genotype VII NDV, strain JS2012 in allantoic fluid was purified by centrifugation at 28000g for 12h with a 20% sucrose cushion. The purified NDV were emulsified with an equal volume of complete or incomplete Freund’s adjuvant (Sigma-Aldrich) after inactivation with a 0.02% final concentration of β-propiolactone, and inoculated into one month old SPF chickens through muscle injection. The chickens were boosted with the live virus after the immunization twice with two week intervals. The immunosera were prepared on day 30 after the last immunization after being drawn from the heart and titrated using HI assay. All experiments involving experimental chickens were approved by the Animal Ethics Committee of Harbin Veterinary Research Institute (HVRI), and conducted according to HVRI guidelines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!